This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goswami, S Articles by Siddiqui, M A Search for Related Content PubMed PubMed Citation Articles by Goswami, S Articles by Siddiqui, M A

Differential expression of the myocyte enhancer factor 2 family of transcription factors in development: the cardiac factor BBF-1 is an early marker for cardiogenesis.

Department of Anatomy and Cell Biology, State University of New York Health Science Center at Brooklyn 11203.

ABSTRACT

In the present study, we have used single chicken blastoderms of defined early developmental stages, beginning with the prestreak stage, stage 1 (V. Hamburger and H. L. Hamilton, J. Morphol. 88:49-92, 1951), to analyze the onset of cardiac myogenesis by monitoring the appearance of selected cardiac muscle tissue-specific gene transcripts and the functional expression of the myocyte enhancer factor 2 (MEF-2) proteins. Using gene-specific oligonucleotide primers in reverse transcriptase PCR assay, we have demonstrated that the cardiac myosin light-chain 2 (MLC2) and alpha-actin gene transcripts appear as early as stage 5, i.e., immediately after the cardiogenic fate assignment at stage 4. Consistent with this observation is the developmental expression pattern of DNA-binding activity of BBF-1, a cardiac muscle-specific member of the MEF-2 protein family, which also begins at stage 5 prior to MEF-2. Differential expression of DNA-binding complexes is also observed with another AT-rich DNA sequence (CArG box) as probe, but the binding pattern with the ubiquitous TATA-binding proteins remains unchanged during the same developmental period. Thus, the cardiogenic commitment and differentiation of the precardiac mesoderm, as exemplified by the appearance of cardiac MEF-2, MLC2, and alpha-actin gene products, occur earlier than previously thought and appear to be closely linked. The onset of skeletal myogenic program follows that of the cardiogenic program with the appearance of skeletal MLC2 at stage 8. We also observed that mRNA for the MEF-2 family of proteins appears as early as stage 2 and that for CMD-1, the chicken counterpart of MyoD, appears at stage 5. The temporal separation of activation of cardiac and skeletal MLC2 genes, which appears immediately after the respective fate assignments, and those of cardiac MEF-2 and CMD-1, which occur before, are consistent with the established appearance of the myogenic programs and with the acquisition pattern of the two tissue-specific morphological characteristics in the early embryo. The preferential appearance of BBF-1 activity in precardiac moesderm, relative to that of MEF-2, indicates that these two protein factors are distinct members of the MEF-2 family and provides a compelling argument in support of the potential role of BBF-1 as a regulator of the cardiogenic cell lineage determination, while cardiac MEF-2 might be involved in maintenance of the cardiac differentiative state.

This article has been cited by other articles:

• Mathew, S., Mascareno, E., Siddiqui, M. A. Q. (2004). A Ternary Complex of Transcription Factors, Nished and NFATc4, and Co-activator p300 Bound to an Intronic Sequence, Intronic Regulatory Element, Is Pivotal for the Up-regulation of Myosin Light Chain-2v Gene in Cardiac Hypertrophy. J. Biol. Chem. 279: 41018-41027 [Abstract] [Full Text]  
• WAGNER, M., MASCARENO, E., SIDDIQUI, M.A.Q. (1999). Cardiac Hypertrophy: Signal Transduction, Transcriptional Adaptation, and Altered Growth Control. Ann. N. Y. Acad. Sci. 874: 1-10 [Abstract] [Full Text]  
• Mascareno, E., Dhar, M., Siddiqui, M. A. Q. (1998). Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: A cellular signal for hypertrophy in cardiac muscle. Proc. Natl. Acad. Sci. USA 95: 5590-5594 [Abstract] [Full Text]  
• Harada, S.-i., Sampath, T. K., Aubin, J. E., Rodan, G. A. (1997). Osteogenic Protein-1 Up-Regulation of the Collagen X Promoter Activity Is Mediated by a MEF-2-Like Sequence and Requires an Adjacent AP-1 Sequence. Mol. Endocrinol. 11: 1832-1845 [Abstract] [Full Text]  
• Bishopric, N. H., Zeng, G.-Q., Sato, B., Webster, K. A. (1997). Adenovirus E1A Inhibits Cardiac Myocyte-specific Gene Expression through Its Amino Terminus. J. Biol. Chem. 272: 20584-20594 [Abstract] [Full Text]  
• Dhar, M., Mascareno, E. M., Siddiqui, M. A. Q. (1997). Two Distinct Factor-binding DNA Elements in Cardiac Myosin Light Chain 2 Gene Are Essential for Repression of Its Expression in Skeletal Muscle. ISOLATION OF A cDNA CLONE FOR REPRESSOR PROTEIN NISHED. J. Biol. Chem. 272: 18490-18497 [Abstract] [Full Text]  
• Mably, J. D., Liew, C.-C. (1996). Factors Involved in Cardiogenesis and the Regulation of Cardiac-Specific Gene Expression. Circ. Res. 79: 4-13 [Abstract] [Full Text]